David Rosen – ANIP history
- Issuer:
- ANI PHARMACEUTICALS INC
- Quarters tracked:
- 15 (Q3 2022 → Q2 2026)
- Current shares:
- 258,131
- Current value:
- $21.37M
- Peak shares:
- 1,125,000 (Q4 2023)
- Overall change:
- -10%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 258,131 | $21.37M | $82.78 | +258,131 | +100% |
| Q4 2025 | SOLD | — | — | -343,414 | -100% |
| Q3 2025 | 343,414 | $31.46M | $91.60 | +85,745 | +33% |
| Q2 2025 | 257,669 | $16.81M | $65.25 | +200,998 | +355% |
| Q1 2025 | 56,671 | $3.79M | $66.95 | 0 | 0% |
| Q4 2024 | 56,671 | $3.13M | $55.28 | 0 | 0% |
| Q3 2024 | 56,671 | $3.38M | $59.66 | -547,129 | -91% |
| Q2 2024 | 603,800 | $38.45M | $63.68 | -354,733 | -37% |
| Q1 2024 | 958,533 | $66.26M | $69.13 | -166,467 | -15% |
| Q4 2023 | 1,125,000 | $62.03M | $55.14 | +277,989 | +33% |
| Q3 2023 | 847,011 | $49.18M | $58.06 | 0 | 0% |
| Q2 2023 | 847,011 | $45.59M | $53.83 | +198,970 | +31% |
| Q1 2023 | 648,041 | $25.74M | $39.72 | +271,909 | +72% |
| Q4 2022 | 376,132 | $15.13M | $40.23 | +89,086 | +31% |
| Q3 2022 | 287,046 | $9.23M | $32.14 | — | NEW |